Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 121

Results For "portfolio"

1611 News Found

Merck presents positive results from phase 1/2 study evaluating V116
News | June 22, 2022

Merck presents positive results from phase 1/2 study evaluating V116

V116 designed to target serotypes that account for 85% of all invasive pneumococcal disease in individuals aged 65 and over in the United States as of 2019


Medix Biochemica acquires Bioresource Technology
News | June 21, 2022

Medix Biochemica acquires Bioresource Technology

Bioresource Technology's state of the art manufacturing facility in Weston, Florida


ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer
People | June 15, 2022

ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer

Gilman will be responsible for all business development and portfolio strategy efforts globally.


Merck KGaA collaborates with University of Bonn to advance molecular machine learning
Digitisation | June 15, 2022

Merck KGaA collaborates with University of Bonn to advance molecular machine learning

The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning


Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions
Supply Chain | June 15, 2022

Etihad Cargo signs MOU for sustainable pharmaceutical transportation solutions

Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals


FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer
Drug Approval | June 14, 2022

FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer

Acceptance based on results from the phase 3 KEYNOTE-091 trial


Strides receives USFDA approval for Ibuprofen OTC oral suspension
Drug Approval | June 12, 2022

Strides receives USFDA approval for Ibuprofen OTC oral suspension

Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.


Olema Oncology and Aurigene collaboration to discover and develop novel cancer therapies
News | June 10, 2022

Olema Oncology and Aurigene collaboration to discover and develop novel cancer therapies

During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.


Prolacta Bioscience appoints David Steinberg as CFO
People | June 08, 2022

Prolacta Bioscience appoints David Steinberg as CFO

Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.


Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform
News | June 07, 2022

Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform

Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues